Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Gebre-Medhin

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 5, 2026
Circulating Tumor DNA in Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Carcinoma-Are We Ready to Individualize Treatment?Maria Gebre-Medhin, Gabriel Adrian
International Journal of Radiation Oncology, Biology, Physics|November 16, 2024
Probably Not!Gabriel Adrian, Maria Gebre-Medhin
Acta Oncologica (Stockholm, Sweden)|September 8, 2023
Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumorsGabriel Adrian, Maria Gebre-Medhin, Per Nilsson
Clinical and Translational Radiation Oncology|June 30, 2022
Hypoxia in relationship to tumor volume using hypoxia PET-imaging in head & neck cancer - A scoping reviewSofia Hildingsson, Maria Gebre-Medhin, Sebastian Zschaeck, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2026
Six versus five fractions per week (Chemo)-Radiotherapy for locally advanced head and neck squamous cell carcinoma - A nationwide cohort study from the swedish head and neck cancer registerGabriel Adrian, Niclas Rudolfson Falklind, Lachlan McDowell, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2025
Chemoradiotherapy vs Radiotherapy Alone in T1-2 Oropharyngeal Cancer with Low Volume Neck Disease: A Population-Based Cohort Study Utilizing the XXXXX Head and Neck Cancer RegisterGabriel Adrian, Niclas Rudolfson Falklind, Lachlan McDowell, et al.
Head & Neck|May 11, 2026
External Validation of Pre-Treatment Primary Tumor Volume as a Prognostic Factor in Head and Neck Cancer Treated With (Chemo)RadiotherapyGabriel Adrian, Andre Haraldsson Änghede, Lachlan McDowell, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 29, 2023
Circulating tumour HPV16 DNA quantification - A prognostic tool for progression-free survival in patients with HPV-related oropharyngeal carcinoma receiving curative chemoradiotherapyGabriel Adrian, Ola Forslund, Louise Pedersen, et al.
Acta Oncologica (Stockholm, Sweden)|September 6, 2016
Dose-volume analysis of radiation-induced trismus in head and neck cancer patientsMaria Gebre-Medhin, Mahnaz Haghanegi, Lotta Robért, et al.
Head & Neck|March 21, 2020
Altered fractionation diminishes importance of tumor volume in oropharyngeal cancer: Subgroup analysis of ARTSCAN-trialGabriel Adrian, Maria Gebre-Medhin, Elisabeth Kjellén, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|February 5, 2026
Circulating Tumor DNA in Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Carcinoma-Are We Ready to Individualize Treatment?Maria Gebre-Medhin, Gabriel Adrian
International Journal of Radiation Oncology, Biology, Physics|November 16, 2024
Probably Not!Gabriel Adrian, Maria Gebre-Medhin
Acta Oncologica (Stockholm, Sweden)|September 8, 2023
Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumorsGabriel Adrian, Maria Gebre-Medhin, Per Nilsson
Clinical and Translational Radiation Oncology|June 30, 2022
Hypoxia in relationship to tumor volume using hypoxia PET-imaging in head & neck cancer - A scoping reviewSofia Hildingsson, Maria Gebre-Medhin, Sebastian Zschaeck, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2026
Six versus five fractions per week (Chemo)-Radiotherapy for locally advanced head and neck squamous cell carcinoma - A nationwide cohort study from the swedish head and neck cancer registerGabriel Adrian, Niclas Rudolfson Falklind, Lachlan McDowell, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2025
Chemoradiotherapy vs Radiotherapy Alone in T1-2 Oropharyngeal Cancer with Low Volume Neck Disease: A Population-Based Cohort Study Utilizing the XXXXX Head and Neck Cancer RegisterGabriel Adrian, Niclas Rudolfson Falklind, Lachlan McDowell, et al.
Head & Neck|May 11, 2026
External Validation of Pre-Treatment Primary Tumor Volume as a Prognostic Factor in Head and Neck Cancer Treated With (Chemo)RadiotherapyGabriel Adrian, Andre Haraldsson Änghede, Lachlan McDowell, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 29, 2023
Circulating tumour HPV16 DNA quantification - A prognostic tool for progression-free survival in patients with HPV-related oropharyngeal carcinoma receiving curative chemoradiotherapyGabriel Adrian, Ola Forslund, Louise Pedersen, et al.
Acta Oncologica (Stockholm, Sweden)|September 6, 2016
Dose-volume analysis of radiation-induced trismus in head and neck cancer patientsMaria Gebre-Medhin, Mahnaz Haghanegi, Lotta Robért, et al.
Head & Neck|March 21, 2020
Altered fractionation diminishes importance of tumor volume in oropharyngeal cancer: Subgroup analysis of ARTSCAN-trialGabriel Adrian, Maria Gebre-Medhin, Elisabeth Kjellén, et al.
Pageof 3